Calidi Biotherapeutics replaces auditor Marcum with CBIZ after Marcum acquisition

Calidi Biotherapeutics, Inc.

Marcum resigned as independent auditor on April 30, 2025, following its acquisition by CBIZ.
Audit Committee approved CBIZ as new auditor for fiscal year ending December 31, 2025.
Marcum's reports for 2023 and 2024 included a going concern explanatory paragraph; no adverse opinions.
No disagreements or reportable events between the company and Marcum during the past two fiscal years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.